COMMUNIQUÉS West-GlobeNewswire

Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
23/05/2024
ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high [...]
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
23/05/2024
TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high [...]
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
23/05/2024
- Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO 1 on annualized revenues of approximately $75 million by Q2 2025- -Strong sequential 39% Q/Q growth on Point-of-Care [...]
Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference
23/05/2024
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical
23/05/2024
IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
REPEAT – Media Conference - Update: Fightback to Save Durham Hospital Ratcheting Up
23/05/2024
TORONTO and GREY BRUCE, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- It is a small community, but it has raised its voice for the whole province to hear. Almost a thousand community members have taken to the streets in [...]
Halo Dental Technologies Showcase Its Digital Mirror at Montreal-based JDIQ Annual Conference
23/05/2024
At the largest bilingual dental convention in North America, Halo will showcase the first-of-its-kind digital dental mirror at its home-city event, for leading dentists and hygienists in Canada. MONTREAL, May 23, 2024 ( [...]
AI-Based Analysis of Dynamic Digital Radiography Data Gives Researchers Greater Insight into Lung Function and Pulmonary Disorders
23/05/2024
WAYNE, N.J., May 23, 2024 (GLOBE NEWSWIRE) -- In a landmark study, the latest in technology innovation by Konica Minolta Healthcare was used to develop a machine-learning-based analysis of X-ray imaging that [...]
Epic Bio to Participate in Fireside Chat at Stifel’s Genetic Medicines Forum
23/05/2024
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced that Amber Salzman, Ph.D., chief [...]
Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
23/05/2024
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) [...]
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
23/05/2024
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the [...]
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
23/05/2024
Differentiated resistance profile positions Traws’ program as a potential class leader NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical [...]
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
23/05/2024
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating [...]
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
23/05/2024
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a [...]
GeneType and Humanise Health host “Know Your Risk” Event
23/05/2024
PASADENA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GeneType”), a global leader in genomics-based tests in health, wellness and serious disease, is [...]
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
23/05/2024
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic [...]
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
23/05/2024
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical [...]
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
23/05/2024
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients [...]
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
23/05/2024
Neumifil delivers statistically significant reductions in influenza symptomatic infection rate, symptom severity and viral load Strategy to advance clinical development of Neumifil to be based on these positive data and [...]

Pages